SCHEMBL29920185

SCHEMBL29920185

COc1c(-c2ccc(C3CCN(C)CC3)cc2)ccc2nc[nH]c(=O)c12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACVR1 Q04771 3/20 0.46
TGFBR1 P36897 1/20 0.46
KCNH2 Q12809 1/20 0.46
MAP4K1 Q92918 3/20 0.46
IL2 P60568 1/20 0.46
BRD9 Q9H8M2 1/20 0.43
IP6K1 Q92551 1/20 0.41
KDM4A O75164 2/20 0.39
KDM4B O94953 2/20 0.39
KDM5C P41229 2/20 0.39
KDM5B Q9UGL1 2/20 0.39
EGFR P00533 2/20 0.39
TNKS O95271 2/20 0.38
PARP1 P09874 2/20 0.38
TNKS2 Q9H2K2 2/20 0.38
ZAP70 P43403 1/20 0.37
SIRT5 Q9NXA8 1/20 0.37
PRKAB2 O43741 1/20 0.37
PRKAG1 P54619 1/20 0.37
PRKAA2 P54646 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL31529591 0.99 ACVR1 (0.45) ACVR1TGFBR1KCNH2MAP4K1IL2
SCHEMBL29440634 0.77 IP6K1 (0.60) ACVR1MAP4K1IL2BRD9IP6K1
Hydrochloric Acid SCHEMBL31529629 0.76 IP6K1 (0.58) ACVR1MAP4K1IL2BRD9IP6K1
SCHEMBL29874700 0.74 EGFR (0.47) MAP4K1BRD9IP6K1KDM4AKDM4B
SCHEMBL3279714 0.74 SRC (0.49) ACVR1TGFBR1MAP4K1IL2EGFR
SCHEMBL29440622 0.74 PARP1 (0.50) ACVR1MAP4K1IL2BRD9IP6K1
SCHEMBL29440635 0.73 MAP4K1 (0.47) ACVR1MAP4K1IL2BRD9IP6K1
SCHEMBL1058891 0.69 ZAP70 (0.62) KCNH2MAP4K1IL2ZAP70SYK
Trifluoroacetic Acid SCHEMBL29919880 0.67 PARP1 (0.53) MAP4K1BRD9IP6K1KDM4AKDM4B
SCHEMBL21886642 0.67 ERBB2 (0.46) EGFRPARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120004861-A Allosteric EGFR inhibitors and methods of use thereof 达纳-法伯癌症研究所股份有限公司 2025-05-16 CN disclosed
CN-115066240-A Allosteric EGFR inhibitors and methods of use thereof 达纳-法伯癌症研究所股份有限公司 2022-09-16 CN disclosed